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LETTERS TO THE EDITORALTERNATIVE SAFER
APPROACH THROUGH THE
CAROTID ARTERY FOR
TRANSCATHETER AORTIC
VALVE IMPLANTATION
To the Editor:
We read with deep interest the case
report by Modine and coauthors1
about the first transcatheter aortic
valve implantation procedure through
the left carotid artery access. The pa-
tient had a transient right hemiparesis
after the procedure, probably because
of the hypoperfusion of the left cere-
bral hemisphere despite the presence
of a healthy circle of Willis or because
of dissection of the left carotid artery.
We would like to mention a modifi-
cation of the carotid access that
addresses both complications. Direct
visual introduction of a sheath through
an open arteriotomy, then snaring the
artery on the introducer and advancing
the hydrophilic guidewire under fluo-
roscopic control would be helpful to
prevent iatrogenic dissection. On the
other hand, perfusion of the distal ca-
rotid artery with the aid of a centrifu-
gal pump (eg, femoral artery to carotid
artery) is an option to prevent the
cerebral hypoperfusion. Our group
successfully performed an experimen-
tal study for endovascular repair of
the aortic arch with distal carotid
perfusion.2
Open carotid arteriotomy access
with distal perfusion would also be
helpful to prevent the embolic shower,
at least to the ipsilateral cerebral hemi-
sphere, during the instrumentation,The Editor welcomes submissions for possible publica-
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The Journalballoon valvuloplasty, and implanta-
tion of the prosthesis. Allowing the
free flow of the proximal carotid artery
for a few seconds would clear off the
debris.
We congratulate Modine and coau-
thors1 for their novel application of
the transcatheter aortic valve implan-
tation procedure.
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We congratulate Arbatlı and col-
leagues on their letter commenting on
the carotid route used to achieve trans-
catheter aortic valve implantation.
They give a reasonable explanation
for the transient ischemic accident
the patient experienced in our reported
case. Indeed, hypoperfusion of the left
cerebral hemisphere may have played
a major role. This was probably
mostly related to the carotid dissection
that occurred initially. Arbatlı and
colleagues suggest ameliorating this
technique by direct visualization ofof Thoracic and Cardiovascular Surgesheath introduction through the open
arteriotomy under fluoroscopic con-
trol. This precaution is now used in
all our surgical transcatheter aortic
valve implantations with carotid and
subclavian arteries.1 They also sug-
gest, on the basis of an experimental
study that they performed,2 the use
of distal perfusion centrifugal pumps.
We do not recommend that technique.
Indeed, the rationale behind transcath-
eter aortic valve implantation is to
achieve minimally invasive implanta-
tion procedures. A complete study of
circle of Willis perfusion, together
with a full respect of the different steps
to achieve this indication, could guar-
antee the success of this procedure.
Indeed, without the occurrence of
any complications, our group per-
formed implantations in additional pa-
tients by this pathway. Finally Arbatlı
and colleagues point out the advantage
of this surgical access as offering the
possibility of preventing potential
ipsilateral embolic shower during the
balloon valvuloplasty and the valve
implantation itself, which are the
highest moments of cerebral embolic
risks. Indeed, the carotid arteriotomy
could be used as a window to clear
off atherosclerotic debris during the
procedure.
Transcatheter aortic valve implan-
tation indications are growing. Ex-
changes of experiences are needed
to optimize surgical implications and
results.
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SWITCH FOR TRANSPOSITION
OF THE GREATARTERIES,
VENTRICULAR SEPTAL
DEFECT, AND PULMONARY
VASCULAR OBSTRUCTIVE
DISEASE
To the Editor:
We read with interest the article by
Lei and associates1 on palliative arte-
rial switch for transposition of the
great arteries, ventricular septal de-
fect, and pulmonary vascular obstruc-
tive disease. We agree with them that
the palliative arterial switch operation
is definitely a better option than the
palliative atrial switch operation. At
our institution, we have performed 3
such operations in the past 2 years
with a different approach. In these 3
patients, aged 1.5 years, 4.5 years,
and 11 years, we used a simplified
unidirectional-valved patch to close
the ventricular septal defect (VSD).
The surgical technique of construction
of this patch was described in detail by
us earlier.2 All 3 of these patients had
severe pulmonary arterial hyperten-
sion with pulmonary artery systolic
pressures of 110 mm Hg, 126 mm
Hg, and 110 mmHg with a pulmonary
vascular resistance of 9.5 units, 7
units, and 17.1 units, respectively. In-
traoperative transesophageal echocar-
diography was used to see the
direction of shunting across the patch
after termination of cardiopulmonary
bypass. In all 3 patients there was ev-
idence of right-to-left shunt through
the valved patch with mild systemic
desaturation. Postoperative recovery
was uneventful in all 3 patients except
for episodic systemic desaturation in
the first 2 patients, which was docu-
mented on echocardiography to be
due to right-to-left shunt across the848 The Journal of Thoracic and Cpatch. The current follow-up of these
patients is 3 months, 1 year, and 1
month, respectively, and these pa-
tients have systemic saturation in
excess of 95% with no right-to-left
shunting across the patch. The second
patient had a cardiac catheterization 8
months after the operation, and the
pulmonary artery systolic pressure
has fallen to 49 mm Hg.
On the basis of our small experi-
ence with this technique, we believe
that a unidirectional-valved patch
may be a better alternative to an
open or partially closed VSD. The ob-
vious advantage is that a repeat inva-
sive procedure to close the VSD is
avoided. Moreover, this strategy also
avoids the costs of a repeat cardiac
catheterization and the substantial
cost of the device used to close the
VSD. In many parts of the world,
these are important considerations.
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We read with interest the letter to
the Editor by Talwar, Choudhary,
and Airan on palliative arterial switch
for transposition of the great arteries,
ventricular septal defect, and pulmo-
nary vascular obstructive disease.
We appreciate the insightful contribu-
tion of their experience with
unidirectional-valved patch to close
the ventricular septal defect (VSD)ardiovascular Surgery c March 2011in 3 patients, with apparently satisfac-
tory short to midterm outcomes (mean
follow-up of 5.3 months). The ratio-
nale for this approach is obviously
an attempt to save the patients from
the additional financial burden of
future device closure of the VSD.
Although patients with VSDs pre-
senting late for surgical closure with
moderate-to-severe PVOD are rare in
developed countries, they account for
a significant percentage of our patient
population in China (possibly the
same in other developing countries),
and we do have rather extensive expe-
rience with unidirectional-valved
patch closures of VSDs in this unique
patient population in the 1990s. What
we found was that if there was no per-
sistent or intermittent right-to-left
shunt at theventricular level, the unidi-
rectional valvewould be stuck and per-
manently closed within a relatively
short period of time (a few weeks to
a few months). In our article, 50% of
our survivors (9/18) had persistent or
even progressive PVOD up to 4 years
of mean follow-up time. When these
patients have occasional exacerbation
of their pulmonary hypertension with
suprasystemic right ventricular pres-
sure, their VSD fenestrations become
their only way of survival. With recent
domestic production of the Amplatzer
occluder device in China, the cost of
transcatheter VSD device closure has
fallen markedly. In our opinion, fenes-
trated VSD closure in this patient pop-
ulation confers a higher postoperative
safety index with a small price to pay.
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